# Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease

> **NCT03692221** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University Hospitals Cleveland Medical Center**

## Conditions studied

- Disc Degeneration

## Interventions

- **DRUG:** MSC Treatment group 1 (low dose)
- **DRUG:** MSC Treatment group 2 (high dose)
- **OTHER:** Healthy Control (no treatment)

## Key facts

- **NCT ID:** NCT03692221
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-06
- **Primary completion:** 2021-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Stalled due to Covid
- **Last updated:** 2022-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03692221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03692221, "Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03692221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*